Literature DB >> 20184987

Prediagnosis food patterns are associated with length of survival from epithelial ovarian cancer.

Therese A Dolecek1, Bridget J McCarthy, Charlotte E Joslin, Caryn E Peterson, Seijeoung Kim, Sally A Freels, Faith G Davis.   

Abstract

BACKGROUND: Dietary factors have been the focus of many studies on the etiology of ovarian cancer and may potentially affect survival. Indeed, three recent studies outside the United States have suggested that diet plays a role in ovarian cancer survival.
OBJECTIVE: The study purpose was to evaluate the hypothesis that women diagnosed with ovarian cancer whose reported prediagnosis food patterns more closely reflect recommendations for optimal health experience a survival advantage compared with those reporting poorer diets.
DESIGN: A longitudinal follow-up study design was used to examine prediagnosis usual diet effects on survival among 341 Cook County, Illinois, residents diagnosed with epithelial ovarian cancer during 1994-1998. These women participated in a previous case-control study where diet was assessed using a validated food frequency questionnaire. This diet information was categorized utilizing the Dietary Guidelines for Americans 2005. Deaths through 2005 were ascertained using a national death index search. STATISTICAL ANALYSIS: Hazard ratios (HR) and 95% confidence intervals (CI) adjusting for important covariables were obtained from proportional hazards regression models to evaluate diet effects on survival from ovarian cancer.
RESULTS: Comparisons of high to low food group or subgroup intakes demonstrated statistically significant prediagnosis food pattern associations with survival time. Longer survival was associated with total fruits and vegetables (HR 0.61, 95% CI 0.38 to 0.98, P for trend=0.10) and vegetables separately (HR 0.66, 95% CI 0.43 to 1.01, P for trend <0.05). Subgroup analyses showed only yellow and cruciferous vegetables to significantly favor survival. Conversely, a survival disadvantage was shown for meats, not generally recommended (HR 2.28, 95% CI 1.34 to 3.89, P for trend <0.01), and specifically the red and cured/processed meats subgroups. An increased HR was also observed for the milk (all types) subgroup (HR 2.15, 95% CI 1.20 to 3.84, P for trend <0.05).
CONCLUSIONS: Prediagnosis adherence to diets that reflect recommendations for optimal nutrition and cancer prevention may have benefits that continue even after an ovarian cancer diagnosis. Copyright 2010 American Dietetic Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20184987     DOI: 10.1016/j.jada.2009.11.014

Source DB:  PubMed          Journal:  J Am Diet Assoc        ISSN: 0002-8223


  22 in total

Review 1.  Mechanisms of action of isothiocyanates in cancer chemoprevention: an update.

Authors:  Sandi L Navarro; Fei Li; Johanna W Lampe
Journal:  Food Funct       Date:  2011-09-21       Impact factor: 5.396

2.  A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) Study.

Authors:  Cynthia A Thomson; Tracy E Crane; Austin Miller; David O Garcia; Karen Basen-Engquist; David S Alberts
Journal:  Contemp Clin Trials       Date:  2016-07-06       Impact factor: 2.226

Review 3.  Association between dietary intake and risk of ovarian cancer: a systematic review and meta-analysis.

Authors:  Alireza Khodavandi; Fahimeh Alizadeh; Ahmad Faizal Abdull Razis
Journal:  Eur J Nutr       Date:  2020-07-13       Impact factor: 5.614

4.  Prediagnostic Proinflammatory Dietary Potential Is Associated with All-Cause Mortality among African-American Women with High-Grade Serous Ovarian Carcinoma.

Authors:  Lauren C Peres; James R Hebert; Bo Qin; Kristin A Guertin; Elisa V Bandera; Nitin Shivappa; Tareq F Camacho; Deanna Chyn; Anthony J Alberg; Jill S Barnholtz-Sloan; Melissa L Bondy; Michele L Cote; Ellen Funkhouser; Patricia G Moorman; Edward S Peters; Ann G Schwartz; Paul D Terry; Joellen M Schildkraut
Journal:  J Nutr       Date:  2019-09-01       Impact factor: 4.798

5.  A dietary pattern associated with LINE-1 methylation alters the risk of developing cervical intraepithelial neoplasia.

Authors:  Chandrika J Piyathilake; Suguna Badiga; Edmond K Kabagambe; Andres Azuero; Ronald D Alvarez; Gary L Johanning; Edward E Partridge
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-18

6.  Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach.

Authors:  Seijeoung Kim; Therese A Dolecek; Faith G Davis
Journal:  Soc Sci Med       Date:  2010-04-22       Impact factor: 4.634

7.  A randomized parallel-group dietary study for stages II-IV ovarian cancer survivors.

Authors:  Raheem J Paxton; Celia Garcia-Prieto; Maria Berglund; Mike Hernandez; Richard A Hajek; Beverly Handy; Jubilee Brown; Lovell A Jones
Journal:  Gynecol Oncol       Date:  2011-11-23       Impact factor: 5.482

8.  Indole-3-carbinol inhibited tobacco smoke carcinogen-induced lung adenocarcinoma in A/J mice when administered during the post-initiation or progression phase of lung tumorigenesis.

Authors:  Xuemin Qian; Tamene Melkamu; Pramod Upadhyaya; Fekadu Kassie
Journal:  Cancer Lett       Date:  2011-07-02       Impact factor: 8.679

9.  Diet quality and survival after ovarian cancer: results from the Women's Health Initiative.

Authors:  Cynthia A Thomson; Tracy E Crane; Betsy C Wertheim; Marian L Neuhouser; Wenjun Li; Linda G Snetselaar; Karen M Basen-Engquist; Yang Zhou; Melinda L Irwin
Journal:  J Natl Cancer Inst       Date:  2014-10-21       Impact factor: 13.506

10.  The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois.

Authors:  Katherine C Brewer; Caryn E Peterson; Faith G Davis; Kent Hoskins; Heather Pauls; Charlotte E Joslin
Journal:  Ann Epidemiol       Date:  2015-04-18       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.